The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Notice for sabizabulin (Adjutor Healthcare Pty Ltd)
Active ingredients
sabizabulin
Sponsor
Date of review outcome
Lapse date
Type
Provisional determination
Indication
For treatment of SARS-CoV-2 infection in hospitalised patients with moderate to severe COVID-19 infection who are at high risk for Acute Respiratory Distress Syndrome (ARDS)
Therapeutic area
Infectious diseases